315 related articles for article (PubMed ID: 29746292)
1. Empagliflozin-Associated Euglycemic Diabtetic Ketoacidosis.
Soni P; Kumar V; Saradna A; Kupfer Y
Am J Ther; 2018; 25(6):e740-e741. PubMed ID: 29746292
[No Abstract] [Full Text] [Related]
2. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
[TBL] [Abstract][Full Text] [Related]
3. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.
Paul N; Jonklaas J
Diabetes Metab Syndr; 2021; 15(1):361-363. PubMed ID: 33517150
[No Abstract] [Full Text] [Related]
4. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors.
Isaacs M; Tonks KT; Greenfield JR
Intern Med J; 2017 Jun; 47(6):701-704. PubMed ID: 28580740
[TBL] [Abstract][Full Text] [Related]
5. Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.
Koch RA; Clark RF
Am J Ther; 2018; 25(5):e590-e591. PubMed ID: 28452848
[No Abstract] [Full Text] [Related]
6. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin-Associated Diabetic Ketoacidosis.
Chakinala RC; Chang AP; Solanki S; Haq KF; Cho R
Am J Ther; 2018; 25(6):e765-e766. PubMed ID: 29672334
[No Abstract] [Full Text] [Related]
8. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
Masuta P; Johri G; Paul M
Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
[No Abstract] [Full Text] [Related]
9. Euglisemic diabetic ketoacidotic coma caused by dapagliflozin.
Karakaya Z; Topal FE; Topal F; Payza U; Akyol PY
Am J Emerg Med; 2018 Nov; 36(11):2136.e1-2136.e2. PubMed ID: 30150107
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery.
Kuchay MS; Mishra SK; Mehta Y
Diabetes Metab Syndr; 2021; 15(3):909-911. PubMed ID: 33915345
[No Abstract] [Full Text] [Related]
11. Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
Ozer O; Yorulmaz G
J Coll Physicians Surg Pak; 2020 Oct; 30(10):110-111. PubMed ID: 33115581
[TBL] [Abstract][Full Text] [Related]
12. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
13. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
Valek R; Von der Mark J
Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094
[TBL] [Abstract][Full Text] [Related]
14. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Sampani E; Sarafidis P; Dimitriadis C; Kasimatis E; Daikidou D; Bantis K; Papanikolaou A; Papagianni A
BMC Nephrol; 2020 Jul; 21(1):276. PubMed ID: 32669085
[TBL] [Abstract][Full Text] [Related]
15. A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus.
Bilgin S; Duman TT; Kurtkulagi O; Yilmaz F; Aktas G
J Coll Physicians Surg Pak; 2022 Jul; 32(7):928-930. PubMed ID: 35795946
[TBL] [Abstract][Full Text] [Related]
16. Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
Wang AY; Hou SK; Li SJ; Kao WF
Am J Emerg Med; 2017 Feb; 35(2):379.e5-379.e6. PubMed ID: 27614369
[No Abstract] [Full Text] [Related]
17. Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.
Zhang L; Tamilia M
CMAJ; 2018 Jun; 190(25):E766-E768. PubMed ID: 29941433
[No Abstract] [Full Text] [Related]
18. A case series of DKA occurring in patients receiving treatment with SGLT-2 inhibitors.
Bashir J; Nalla P; Peter R; Bain SC; Chudleigh R
Diabetes Obes Metab; 2018 Jul; 20(7):1800-1801. PubMed ID: 29493069
[No Abstract] [Full Text] [Related]
19. [Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].
Breuer TGK; Kampmann K; Wutzler A; Steinfort C; Uhl W; Schmidt WE; Meier JJ
Internist (Berl); 2018 Mar; 59(3):282-287. PubMed ID: 28864828
[TBL] [Abstract][Full Text] [Related]
20. Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis.
Leader R; Cowen J; Rajeev SP
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
